Abstract 1810O
Background
Recently, the Global Leadership Initiative on Malnutrition (GLIM) criteria were proposed to standardize the diagnosis of malnutrition. We aim to determine the nutritional status and the prevalence of malnutrition in cancer inpatients as measured by GLIM criteria, and establish the association between malnutrition with the risk of nosocomial infections (NI) and length of hospital stay.
Methods
Prospective observational study carried out in patients admitted to Oncology Department of General University Hospital of Valencia from November 2019 to March 2020. Nutritional status was evaluated within the first 48 hours after admission. Fat free mass index (FFMI) and phase angle (PA) was measured using a bioelectrical impedance (Akern®), and muscle function using a Jamar® handgrip. Sarcopenia was measured using the cut-off values according to EWGSOP2.
Results
A total of 107 patients were evaluated (mean age 66 years, 66.4% males). Most patients (70.1%) had an advanced disease. On admission, 48 patients (44.9%) presented severe malnutrition and 19 (17.8%) moderate malnutrition based on GLIM criteria. In addition, 77 patients (72%) presented dynapenia and 18 patients (16.8%) sarcopenia. Other parameters of nutritional status were: mean weigh: 67.8 kg, mean BMI: 24 kg/m2, mean FFMI: 18.6 kg/m2 and mean PA: 4.5º. Mean length of stay was 13.9 days. During admission, 43 patients (40,2%) developed a NI, mostly respiratory tract infections (26 patients). Weigh, BMI and FFMI but not PA was significantly lower in patients who developed a NI (p<0.05 in all cases). The proportion of infections was higher in patients with severe malnutrition (25/48, 52.1%) and moderate malnutrition (8/19, 42.1%) as compared with patients with no malnutrition (10/40, 25%), (p=0,035). NI were more common in patients with sarcopenia (61.1% vs. 36%, p=0,044). Length of stay was longer in infected patients (18.6 vs 10.8 days, p<0,024) but was not related to nutritional status.
Conclusions
The prevalence of malnutrition in cancer inpatients is high. Malnutrition measured by GLIM criteria and sarcopenia are associated with a high risk of NI. An adequate nutritional evaluation is essential for a timely implementation nutritional support, to avoid malnutrition, sarcopenia and decrease NI.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
LBA87 - A pragmatic cluster-randomized trial of ambulatory toxicity management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (AToM)
Presenter: Monika Krzyzanowska
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1809O - TRheuMa registry provides real world data on rheumatic immune-related adverse events
Presenter: Karolina Benesova
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1568O - Quality of life in cancer patients treated with immune checkpoint inhibitors: A meta-analysis
Presenter: Brian Gonzalez
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1504O - Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer
Presenter: Omer Dizdar
Session: Proffered Paper - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA87, 1809O and 1568O
Presenter: Marianne Hjermstad
Session: Proffered Paper - Supportive and palliative care
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Stein Kaasa
Session: Proffered Paper - Supportive and palliative care
Resources:
Webcast
Invited Discussant 1810O and 1504O
Presenter: Jayne Wood
Session: Proffered Paper - Supportive and palliative care
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Stein Kaasa
Session: Proffered Paper - Supportive and palliative care
Resources:
Webcast